Share Print

Funding Opportunities in Cancer Research



For assistance with funding, contact: 
Paige Isom, Research Adminstrator,
Funding and Awards
Phone: 314-454-8980




Siteman Cancer Center — Internal

Barnes-Jewish Foundation

Deadline Funding Opportunity Sponsor Amount Description

LOI: July 15, 2015


Application: July 31, 2015

INTERNAL: ACS-Institutional Research Grant ACS $30,000 for one year The Washington University ACS-IRG annually awards up to our investigators a maximum of $30,000 for one year (non-renewable). This program provides pilot funding for junior
faculty conducting cancer research projects to obtain preliminary results that will enable them to compete successfully for national research grants. Investigators already receiving support from the NIH, NSF, ACS or other major organizations are not eligible. Applicants are not required to be members of the Cancer Center.
LOI: July 15, 2015 NEW: Metastatic Breast Cancer Program Grant Opportunity NCCN and Pfizer, Inc.  Approximately $250-350K for two years ($2.0M available to fund 6-8 proposals)  NCCN and Pfizer are committed to funding projects that: (1) Further identify quality and performance gaps in the treatment of MBC with deeper analyses and understandings of the gaps and needs (2) Bring the health care team together to understand gaps in practice and develop strategies (3) Facilitate health care systems and providers to engage patients, caregivers and families in shared decision-making (4) Use evidence-based educational strategies that are aligned with the desired results of the intervention
Sept 1, 2015

Oct 1, 2015
INTERNAL: Siteman Investment Program Siteman Cancer Center Varies from $200,000 to $800,000 over 2 years SCC will fund the following mechanisms: Pre-R01 for WUSTL Medical School Faculty, Pre-R01 for SLU Consortium Faculty and WUSTL Danforth Campus Faculty, Multi-PI Pre-R01 for all SCC members, Pre-SPORE/PPG Program for all SCC Members.
LOI: Sept. 9, 2015 NEW: Conquer Cancer Now Award Concern Foundation $60,000 per year; up to 2 years Proposals must be hypothesis-driven and centered on cancer genetics, cancer cell biology, or cancer immunology. Concern will not fund clinical trials, cancer epidemiology, or behavioral studies. Grants will only be awarded to independent investigators who are at the start of their scientific career (i.e., junior faculty) and are at the level of Assistant Professor (or equivalent with explanation). 
Sept. 15, 2015 INTERNAL: K12 Paul Calabresi Career Development Award for Clinical Oncology WUSM CRTC 75 percent of scholar's salary (Up to $100,00 for min. 2 years); $30,000 per year to support research, travel and tuition The goal of the K12 Paul Calabresi Career Development Award for Clinical Oncology is to train a new generation of highly skilled investigators with specialized expertise who will be well prepared to lead cancer research. The K12 Paul Calabresi program supports the development of senior fellow, postdoctoral scholars, and junior faculty through patient oriented cancer research training, curricula, and mentored projects.
Sept. 24, 2015 NEW: Young Investigator Award Conquer Cancer Foundation of the ASCO $50,000 for 1 year The YIA provides funding to promising investigators to encourage and promote quality research in clinical oncology. The purpose of this research grant is to fund physicians during the transition from a fellowship program to a faculty appointment.
Sept. 24, 2015 NEW: Career Development Award Conquer Cancer Foundation of the ASCO $200,000 over 3 years The CDA is a research grant that provides funding to clinical investigators who have received their initial faculty appointment to establish an independent clinical cancer research program. The cancer research must have a patient-oriented focus, including a clinical research study and/or translational research involving human subjects. Proposals with a predominant focus on in vitro or animal studies (even if clinically relevant) are not allowed. 
Ongoing Cancer Research Grant Application Gateway for Cancer Research No cap - applicants should apply for the amount they believe is needed to conduct their clinical trial The Gateway funds clinical trials that have the potential to make an impact on today's cancer patients. There is no restriction on the type of cancer research that can be submitted to The Gateway for review. We fund studies that target specific cancers, and research that examines the wider-reaching impact of systemic therapies on treatment, and quality of life.